维普中文期刊产品整合服务
24篇 您的检索式:作者名="DIELEMAN W"
    题名 作者 年代 出处 被引量
1Cytokinins in rose bybridain relation to bud break显示文摘DIELEMAN J A VERSTAPPEN F W Nicand B 1997Physiologia Plantarum1997,99,3:1
2The move to housing ownership in temporal and regional context 显示文摘Deurloo M C Clark W A V Dieleman F M 1994Environment and Planning A1994,26,:1
3Reduction of forest soil respiration in response to nitrogen deposition显示文摘Janssens I A Dieleman W Luyssaert S 2010Nature geoscience2010,3,5:1
4Tenure Changes in the Context of Micro - level Family and Macro - level Economic Shihs显示文摘CLARK W A V DEURLOO M C DIELEMAN F M 1994Urban Studies1994,,1:1
5Reduction of forest soil respiration in response to nitrogen deposition显示文摘Janssens I Dieleman W Luyssaert S 0,,05:1
6Reduction of forest soil respiration in response to nitrogen deposition 显示文摘JANSSENS I DIELEMAN W LUYSSAERT S 2010Nature Geoscience2010,3,5:1
7Reduction of forest soil respiration in response to nitrogen deposition显示文摘Janssens I A Dieleman W Luyssaert S 2010Nature Geoscience2010,3,5:1
8Root temperature affects on growth and bud break of Rosa hybrida in relation to cytokinin concentration in xylem sap 显示文摘Dieleman J A Verstappen F W A Kuiper D 1998Scientia Horticuhurae1998,76,34:1
9Reduetion of forest soil respiration in response to nitrogen deposition 显示文摘Janssens I A Dieleman W Luyssaert S 2010Nature Geoseienee2010,3,5:1
10Reduction of soil respiration in response to nitrogen deposition 显示文摘Janssens I A Dieleman W Luyssaert S 2010Nature Geoscience2010,3,:1
11Reduction of forest soil respiration in response to nitrogen deposition 显示文摘Janssens I A Dieleman W Luyssaert S 2010Nature Geo- science2010,3,5:1
12Housing Consumption and Residential Mobility 显示文摘CLARK W A V DIELEMAN F M DEURLOO M C 1984Annals of the Association of American Geographers1984,,74:1
13The Move to Housing Ownership in Temporal and Regional Contexts显示文摘DEURLOO M C CLARK W A V DIELEMAN F M 1994Environment and Planning A1994,,26:1
14Tenure Choice in the Dutch Housing Market显示文摘DEURLO0 M C DIELEMAN F M CLARK W A V 1987Environment and Planning A1987,,19:1
15Co-evolution of institutions and corporations in emerging economies: How the Salim Group morphed into an institution of Suharto's goony regime显示文摘Dieleman M Sachs W M 2008Janrnal of Management Studies2008,45,7:1
16Reduction of soil respiration in response to nitrogen deposition显示文摘Janssens I A W Dieleman S Luyssaert J-A Subke M Reichstein 0,,:1
17Residential mobility and tteighbourbood outcomes显示文摘CLARK W DEURLOO M DIELEMAN F 2006Housing Studies2006,2,3:1
18Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation显示文摘AIM:To investigate genetic differences between Crohn's disease(CD) patients with a sustained remission vs relapsers after discontinuing infliximab while in corticosteroid-free remission.METHODS:Forty-eight CD patients received infliximab and were in full corticosteroid-free clinical remission but then discontinued infliximab for reasons other than a loss of response,were identified by review of an electronic database and charts.Infliximab-associated remission was defined as corticosteroid-free plus normalization of clinical disease activity [CD activity index(CDAI) < 150] during follow-up visits based on physician global assessments.A CD relapse(loss of infliximab-induced remission) was clinically defined as a physician visit for symptoms of disease activity(CDAI > 220) and a therapeutic intervention with CD medication(s),or a hospitalization with complications related to active CD.Genetic analyses were performed on samples from 14 patients(n = 6 who had a sustained long term remission after stopping infliximab,n = 8 who rapidly relapsed after stopping infliximab).Nucleotide-binding oligomerization domain 2(NOD2)/caspase activation recruitment domain 15(CARD15) polymorphisms(R702W,G908R and L1007fs) and the inflammatory bowel disease 5(IBD5) polymorphisms(IGR2060a1 and IGR3081a1) were analyzed in each group.RESULTS:Five single nucleotide polymorphisms of IBD5 and NOD2/CARD15 genes were successfully analyzed for all 14 subjects.There was no significant increase in frequency of the NOD2/CARD15 polymorphisms(R702W,G908R and L1007fs) and the IBD5 polymorphisms(IGR2060a1 and IGR3081a1) in either group of patients;those whose disease relapsed rapidly or those who remained in sustained long term remission following the discontinuation of infliximab.Nearly a third of patients in full clinical remission who stopped infliximab for reasons other than loss of response remained in sustained clinical remission,while two-thirds relapsed rapidly.There was a marked difference in the duration of clinical remission following discontinuance of infliximab between the two groups.The patients who lost remission did so after 1.0 years ± 0.6 years,while those still in remission were at the time of this study,8.1 years ± 2.6 years post-discontinuation of infliximab,P < 0.001.The 8 patients who had lost remission after discontinuing infliximab had a mean number of 5 infusions(range 3-7),with a mean treatment time of 7.2 mo(range 1.5 mo-15 mo).The mean duration of time from the last infusion of infliximab to the time of loss of remission was 382 d(range 20 d-701 d).The 6 patients who remained in remission after discontinuing infliximab had a mean number of 6 infusions(range 3-12),with a mean treatment duration of 12 mo(range 3.6 mo-32 mo)(P = 0.45 relative to those who lost remission).CONCLUSION:There are no IBD5 or NOD2/CARD15 mutations that predict which patients might have sustained remission and which will relapse rapidly after stopping infliximab.Cathy Lu Alistair Waugh Robert J Bailey Raeleen Cherry Levinus A Dieleman Leah Gramlich Kata Matic Mario Millan Karen I Kroeker Daniel Sadowski Christopher W Teshima Dennis Todoruk Clarence Wong Karen Wong Richard N Fedorak 2012World Journal of Gastroenterology2012,18,36:1
19Cone-beam CT in the assessment of mandibular invasion by oral squamous cell carcinoma: results of the preliminary study显示文摘Hendrikx A W Maal T Dieleman F 2010Int J Oral Maxillofac Surg2010,39,5:1
20Falling out of the home owner market显示文摘Dieleman F M Clark W A V Deurloo M C 0,,01:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费